DNMT3A and gout: Notably, Agrawal et al. identified uncertain potential clonal hematopoiesis (CHIP) as a risk factor for gout, particularly mutations in TET2 and DNMT3A, which encode epigenetic regulatory factors (Merriman and Joosten, 2022).